Anti-Ro52 has been shown to be involved in the mechanisms of many rheumatic diseases, including SLE, systemic sclerosis, inflammatory myositis and juvenile idiopathic arthritis (21, 22). The gene discussed is TRIM21; the disease is systemic lupus erythematosus.